Almirall Stock (BME:ALM)


Today's Range
€10.76 - €10.93
52-Week Range
€10.26 - €15.35
Market Cap

About Almirall (BME:ALM)

(BME:ALM) Almirall, S.A., a pharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines worldwide. The company offers its products for dermatological diseases comprising actinic keratosis, atopic dermatitis, cutaneous T-cell lymphoma, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, acne, and orphan indications; and for central nervous system, cardiovascular, and gastrointestinal diseases. Its products include Actikerall, Solaraze, Cordran Tape, Skilarence, Ilumetri, Seysara, Almax, Crestor, Provisacor, Sativex, Ebastel, Aczone, Tazorac, Azelex, and Veltin. Almirall, S.A. has a strategic research collaboration with Evotec AG to discover and develop first-in-class therapeutics in the field of dermatology diseases; collaborative research and license agreement with X-Chem, Inc. for the development of oral compounds for patients suffering from dermatological diseases; research collaboration with Iktos in the area of artificial intelligence for new drug design; multi-target research collaboration with the University of Dundee to develop novel targeted protein degraders medicines; and collaboration with Popit to provide a novel support solution for patients with psoriasis. It also has a strategic partnership with Tyris Therapeutics to develop gene therapies for the treatment of rare genetic dermatology diseases; and Happify Health to develop evidence-supported digital therapeutics solutions for psoriasis patients. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.
Show more

ALM Stock Price

Statistics Highlights (BME:ALM)

Shares Outstanding 179.69M Beta 0.62
Public Float 73.52M P/E Ratio -
% Short of Float - Dividend (Yield) 0.19 (0.02%)
Held by Insiders 59.25% Ex-Dividend Date May 14, 2021
Held by Institutions 17.17% IPO Date Jun 20, 2007

ALM Financial Summary

Dec 20 Dec 19 Dec 18
Revenue €807.43M €855.34M €756.93M
EBITDA €213.35M €272.52M €201.75M
Net Income €74.28M €105.91M €77.67M
Total Assets €2.29B €2.44B €2.39B
Total Cash €165.67M €117.29M €86.27M
Total Debt
Sep 21 Jun 21 Mar 21
Revenue €205.29M €220.60M
EBITDA €-26.79M €72.30M
Net Income €-72.65M €29.80M
Total Assets €2.19B €2.34B
Total Cash €232.53M €61.20M
Total Debt

ALM Stock Price History

Almirall Annual Stock Price History

Year Open Close Change
2022 €11.21 €10.87 -3.03%
2021 €11.03 €11.21 1.63%
2020 €14.88 €11.03 -25.87%

Almirall Daily Stock Price History

Date Open High Low Close Change Volume
Jan 21, 2022 €11.04 €11.08 €10.92 €10.92 -1.44% 353.28K

(BME:ALM) Stock Price FAQs

What is today's stock price of Almirall (BME:ALM)?

  • The current stock price of Almirall (BME:ALM) is €10.87.
  • Today ALM stock price opened at €10.85 after previous close of €10.73.
  • During the day, Almirall stock quote has varied from a low of €10.76 to a high of €10.93.

What is Almirall's 52-week change?

  • ALM 52-week high stock quote is €15.35, which is 41.20% above the current share price.
  • The Almirall (BME:ALM) 52-week low stock price is €10.26, which is 5.60% below the current share price.
  • Almirall share price volatility (52-week beta) is 0.62.

Almirall (BME:ALM) FAQ

How Much is Almirall Worth?

Almirall's worth today based on market capitalisation is €1.93B

How much dividend does Almirall Pay?

The current annualized dividend payout for ALM stock is €0.18, the dividend yield is 1.70% and the payout ratio is 34.85%.
View More Details on Almirall's "Dividend" Section

When is the next earnings date for Almirall (BME:ALM)?

Almirall is expected to report earnings on May 09 ,2022.
View More Details on Almirall's 'Earnings' Section

What is Almirall’s Price to Earning (PE) ratio?

ALM stock also has a Price to Sales (P/S) ratio of 2.37.

What is the Almirall's ticker?

Almirall trades on the Madrid stock market in Spain under the ticker symbol "ALM". Almirall’s stock symbol can also be displayed as "BME:ALM".

When did ALM go public?

Almirall completed its initial public offering (IPO) on June 20 ,2007.

Who are the owners of Almirall?

Almirall (BME:ALM) is owned by 17.17% institutional shareholders and by 59.25% insiders. The rest is owned by the public.
Explore More Details on Almirall's “Ownership” Section

Who are the key executives of Almirall (ALM)?

Almirall's key executive team includes the following managers:

  • Dr. Jorge Gallardo Ballart, Chairman & Pres (1941)
  • Mr. Gianfranco Nazzi, CEO & Exec. Director (1969)
  • Mr. Michael McClellan, Exec. VP of Fin., CFO & Member of Management Board (1971)
  • Mr. Joan Figueras Carreras, Gen. Counsel, Corp. Director, Vice Sec., Member of Mgmt. Board & Non-Voting Director (NA)
  • Mr. Eloi Crespo Cervera, Sr. VP of Industrial Operations & Member of Management Board (NA)
  • Dr. Francesca Domenech Wuttke Ph.D., Chief Digital Officer & Member of Management Board (NA)
  • Mr. Jordi Sabé Richer, Sr. VP of Corp. Devel. & Member of Management Board (NA)
  • Mr. Esteve Conesa Panicot, Sr. VP of HR & Member of Management Board (NA)
  • Dr. Volker Koscielny, Chief Medical Officer & Member of Management Board (NA)
  • Mr. Pablo Alvarez, Member of Management Board, Pres of Almirall US & GM of Almirall US (NA)

What is Almirall’s Sector & Industry Classification?

Almirall (BME:ALM) is classified under the "Healthcare" sector and under the "Drug Manufacturers-Specialty & Generic" industry.

How many employees work for Almirall?

Currently the number of employees working for Almirall is 1,787.

Where are Almirall's Headquarters?

Almirall (BME:ALM) is headquartered in Spain.

What are Almirall's Address and Phone Number?

Almirall’s mailing address is Ronda Del General Miter, 151, Barcelona, Spain, 08022.
The company’s phone number is 34 93 291 30 00.

What is the official website for Almirall?

Almirall’s official website is